Caleres (CAL) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Q3 2024 net sales were $740.9M, down 2.8% year-over-year, mainly due to lower Famous Footwear sales, a retail calendar shift, and softer boot demand; Brand Portfolio sales rose 0.7%.
Adjusted EPS was $1.23, excluding $0.04/share in restructuring charges, and EBITDA reached $73M (9.9% margin); reported EPS was $1.19.
Direct-to-consumer sales accounted for 72% of net sales; both segments gained market share despite overall sales decline.
Performance was impacted by soft boot sales, late athletic product receipts, a credit issue with a Brand Portfolio customer, and weaker China business.
Share repurchases totaled $50M (1.5M shares) in Q3, with strong liquidity and working capital improvement.
Financial highlights
Q3 gross margin was 44.1%, down 55 bps year-over-year; Brand Portfolio margin up 15 bps to 43.8%, Famous margin down 130 bps to 42.9%.
Operating earnings were $56.7M (7.9% margin); adjusted EBITDA margin was 9.9%.
Net earnings attributable to shareholders were $41.4M, down from $46.9M last year.
Inventory at quarter end was $586M, up 5.4% year-over-year (2.7% adjusted for calendar shift).
Total liquidity at quarter-end was $285.8M; net borrowings under the revolving credit agreement were $238.5M.
Outlook and guidance
Full-year 2024 net sales expected to decline 2.5%–3%; operating margin forecast at 6.1%–6.3%.
Adjusted EPS guidance lowered to $3.45–$3.55, excluding $0.10/share in restructuring costs.
Capital expenditures expected at $50–$55M, mainly for store remodels and ERP implementation.
Q4 outlook assumes continued boot softness, aggressive inventory clearance, and gross margin pressure.
Plans to reduce borrowings under the revolving credit agreement to mitigate high interest expense.
Latest events from Caleres
- Brand Portfolio drove 8.5% sales growth and margin gains, offsetting Famous Footwear declines.CAL
Q1 20279 Jun 2026 - Director elections, auditor ratification, and compensation plan up for vote at annual meeting.CAL
Proxy filing16 Apr 2026 - Shareholders will vote on directors, auditor, compensation plan, and executive pay amid strategic growth.CAL
Proxy filing16 Apr 2026 - Q4 and FY25 beat guidance as e-commerce and Brand Portfolio drive margin and earnings recovery.CAL
Q4 202619 Mar 2026 - Sales down 1.8% as ERP disruptions and weak demand led to lower results and revised guidance.CAL
Q2 202520 Jan 2026 - FY24 met guidance; FY25 outlook cautious with Stuart Weitzman acquisition and sourcing shift.CAL
Q4 202526 Dec 2025 - Sales up 6.6% with strong brands, but margins and EPS pressured by tariffs and integration.CAL
Q3 202611 Dec 2025 - Disciplined management, strong brands, and robust governance position the company for future growth.CAL
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, executive pay, and auditor ratification at annual meeting.CAL
Proxy Filing1 Dec 2025